30 Day
BPC-157 for Injury Recovery and Pain: A Citizen Science Trial
| STUDY TITLE | BPC-157 for Injury Recovery and Pain: A Citizen Science Trial |
|---|---|
| Submitted under umbrella | |
| Date submitted |
- |
| End date |
There is no pre-specified end date and sub-studies remain open long-term. |
| Language |
English |
| Efforia AI IRB approval recommendation | |
| Recruitment page preview | |
| Author edit | |
| Informed consent | |
| Study author |
Matthew Amsden, Matthew Amsden, Matthew Amsden |
| Principal investigator |
Matthew Amsden |
| Sub-Investigator for Adverse Events |
Dr. Viral Patel |
| Description |
BPC-157, discovered in the early 1990s is a peptide showing significant promise in speeding injury recovery, reducing associated pain, and thus improving quality of life. While there is a lot of anecdotal evidence, strong clinical trial data is lacking, leading to regulatory guidance that may affect availability. This trial aims to help build this data, establish efficacy and show BPC-157's strong safety profile. |
| Participant engagement length |
30 Days |
| Sponsor |
This study is made possible by your payment to cover all supplies and expenses required to participate. |
| Cost to participant |
$0 |
| Included products & services |
Inflammation Blood Test: $137
Oura Ring: $0
|
| Outcome measures |
PROMIS Bank v1.1 – Pain Interference Inflammation Blood Test Quality of Life and Health Survey |
| Methodology |
Single Arm longitudinal where participants act as their own control |
| Basic or advanced dissemination plan |
Basic |
| Deviation from recruitment approach |
No |
| Deviation from statistical approach |
No |
| Will study include “more about you questions” |
Yes |
| Recruitment jurisdictions |
United States, United Kingdom |
| Clinicaltrials.Gov |
Yes |
| Committment to list findings on clinicaltrials.Gov |
Yes |
Preview This document is prepared with the assistance of AI, but is reviewed by a human.
Rational & Study Design
This trial aims to address the paradox of widespread BPC-157 usage by directing it into a systematic and controlled clinical study using the principles of Efforia’s citizen science model. Our mission is to provide robust and scientifically rigorous data on the effects, safety, and efficacy of BPC-157 while creating a legitimate pathway for the extensive grey market for BPC-157. We seek to generate valuable data for the scientific community that could potentially inform future trials and contribute to FDA consideration and approval.
Our approach to this trial prioritizes participant safety. We will implement rigorous scientific protocols to systematically collect collect adverse events as opposed to the purely anecdotal chatroom and side conversation orientation today.
Through these stringent safety measures, this trial is designed to shed light on the true risk-benefit profile of BPC-157, providing a clearer understanding of its potential in a controlled and scientifically rigorous manner.
The primary objective of this trial is to evaluate the safety and efficacy of BPC-157 in promoting inflammation reduction and pain related injury recovery. Specific objectives include:
1. To categorically assess the safety of BPC-157 administration in humans, specifically its side effect profile and any adverse events.
2. To evaluate the efficacy of BPC-157 in pain and inflammation reduction in injury recovery, using objective measures such as blood inflammation markers and time to complete recovery, and subjective measures such as pain scores and quality of life measures.
3. To collect preliminary data for the design of future randomized controlled trials on BPC-157.
4. To evaluate any potential impact on mood and cognative health, from which may inform another trial on the impact of BPC-157’s proposed neuroprotective properties.
Hypothesis Statement
The daily administration of BPC-157 near the site of an injury could potentially accelerate the recovery process of phy
The Intervention
Included Products & Services
Product Name: Inflammation Blood Test
Quantity included: 2
Price: $137.00
Product Description: Efforia, in partnership with Tasso, introduces the "Inflammation" test, featuring Cortisol and hsCRP measurements. Our easy-to-use, shoulder-attached device gently collects a minimal blood sample non-invasively. Though a bit pricier, it's much more comfortable than conventional methods, ideal for those wary of needles. Just mail it back in the enclosed pre-paid envelope for analysis. Convenient, efficient, and pain-free.
Product Image:
Ingredients:
Product Safety:
Product Name: Oura Ring
Quantity included: 1
Price: $0.00
Product Description:
Product Image:
Ingredients:
Product Safety:
Study Design & Methodology
Inappropriate Participants & Inclusion/Exclusion
Study Design & Experience
Statistical Analysis Plan
Limitations & Justification
Human Subjects Ethics
Suitability Under Minimal Risk Umbrella Protocol
Suitability for Pay to Participate Model
Human Subjects Protection Questionnaire
Logging
Logging
| Date | Event | Message | Name |
|---|---|---|---|
| No records found. | |||